DE3882233D1 - Gefaessaktive peptide. - Google Patents

Gefaessaktive peptide.

Info

Publication number
DE3882233D1
DE3882233D1 DE8888908781T DE3882233T DE3882233D1 DE 3882233 D1 DE3882233 D1 DE 3882233D1 DE 8888908781 T DE8888908781 T DE 8888908781T DE 3882233 T DE3882233 T DE 3882233T DE 3882233 D1 DE3882233 D1 DE 3882233D1
Authority
DE
Germany
Prior art keywords
vessel
active peptides
formula
same
different
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888908781T
Other languages
English (en)
Other versions
DE3882233T2 (de
Inventor
Per Melin
Jerzy Trojnar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring AB
Original Assignee
Ferring AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring AB filed Critical Ferring AB
Publication of DE3882233D1 publication Critical patent/DE3882233D1/de
Application granted granted Critical
Publication of DE3882233T2 publication Critical patent/DE3882233T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE88908781T 1987-10-07 1988-10-04 Gefässaktive peptide. Expired - Fee Related DE3882233T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8703855A SE469473B (sv) 1987-10-07 1987-10-07 Vasoaktiva peptider

Publications (2)

Publication Number Publication Date
DE3882233D1 true DE3882233D1 (de) 1993-08-12
DE3882233T2 DE3882233T2 (de) 1993-10-21

Family

ID=20369772

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88908781T Expired - Fee Related DE3882233T2 (de) 1987-10-07 1988-10-04 Gefässaktive peptide.

Country Status (10)

Country Link
EP (1) EP0380554B1 (de)
JP (1) JPH03500409A (de)
AT (1) ATE91286T1 (de)
AU (1) AU606476B2 (de)
DE (1) DE3882233T2 (de)
DK (1) DK87090A (de)
FI (1) FI901773A0 (de)
NO (1) NO901558L (de)
SE (1) SE469473B (de)
WO (1) WO1989003393A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE502644C2 (sv) * 1990-02-27 1995-11-27 Ferring Ab Vasoaktiva vasotocinderivat
JO2937B1 (en) 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
CA2641959C (en) 2006-02-10 2016-12-20 Ferring B.V. Novel compounds
WO2009037586A2 (en) 2007-08-14 2009-03-26 Ferring B.V. Use of peptidic vasopressin receptor agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL129421C (de) * 1963-08-30 1900-01-01
CH455823A (de) * 1964-08-01 1968-05-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von Peptiden

Also Published As

Publication number Publication date
DE3882233T2 (de) 1993-10-21
SE8703855L (sv) 1989-04-08
DK87090A (da) 1990-06-01
AU2533988A (en) 1989-05-02
SE8703855D0 (sv) 1987-10-07
JPH03500409A (ja) 1991-01-31
DK87090D0 (da) 1990-04-06
NO901558D0 (no) 1990-04-05
SE469473B (sv) 1993-07-12
EP0380554B1 (de) 1993-07-07
AU606476B2 (en) 1991-02-07
FI901773A0 (fi) 1990-04-06
EP0380554A1 (de) 1990-08-08
NO901558L (no) 1990-04-05
WO1989003393A1 (en) 1989-04-20
ATE91286T1 (de) 1993-07-15

Similar Documents

Publication Publication Date Title
ATE266043T1 (de) Peptidanaloge des menschlichen basischen myelinproteins
ATE121755T1 (de) Deletionsanaloga von magaininpeptiden.
ES526201A0 (es) Un procedimiento para preparar un peptido que tiene influencia sobre la funcion de la glandula pituitaria
IL104325A (en) Variants of human kunitz-type protease inhibitor domain II of tissue factor pathway inhibitor (TFPI) pharmaceutical compositions containing them a DNA construct encoding them their expression vectors a cell containing said DNA constructs and methods for the production of all the above
HUP0003592A2 (hu) LH-RH peptid analógok, alkalmazásuk, és ezeket tartalmazó gyógyászati készítmények
RU94045952A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена
RU94036776A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена ингибитора протеазы
DK0466174T3 (da) Hidtil ukendt fysiologisk aktivt svinepeptid (CNP-53)
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
MX9703642A (es) Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana.
BR9306272A (pt) Peptídeo e composiçao farmacêutica
FR2546164B1 (fr) Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
ATE146188T1 (de) Substituierungsanaloge von magaininpeptiden
ES2196187T3 (es) Conjugados peptidicos derivados de las hormonas timicas, su utilizacion a titulo de medicamento y composiciones que los contienen.
ATE182899T1 (de) Gnrh analoge
GR852541B (de)
DE3882233D1 (de) Gefaessaktive peptide.
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
CA2076749A1 (en) Vasoactive vasotocin derivatives
ATE124955T1 (de) Substrat-peptide.
EP0687685A4 (de) Physiologisch-aktive peptide
SE9101586D0 (sv) Modified thioredoxin and its use
SE8901278L (sv) Peptidderivat
SE9003040D0 (sv) Analogues of cyclolinopeptide a and the use thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee